Table 1 Association between RALYL expression and clinicopathologic features in 117 HCC cases.

From: RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2

Features

Total

RALYL expressiona

P-value

Absent

Present

Sex

   

0.985

   Male

98

72

26

 

   Female

19

14

5

 

Age (years)

   

0.812

   ≤60

96

71

25

 

   >60

21

15

6

 

Serum AFP (ng/mL)

   

0.075

   ≤400

65

52

13

 

   >400

52

34

18

 

Serum HBsAg

   

0.643

   Negative

16

11

5

 

   Positive

101

75

26

 

Cirrhosis

   

0.047

   Absent

36

22

14

 

   Present

80

63

17

 

Differentiation

   

0.044

   Well/moderate

67

54

13

 

   Poor

50

32

18

 

Tumor size

   

0.205

   ≤5

49

39

10

 

   >5

68

47

21

 

TNM stage (AJCC)

   

0.559

   I

84

63

21

 

II/III

33

23

10

 

Vascular invasion

   

0.020

   Absent

102

78

24

 

   Present

13

6

7

 

Metastasis

   

0.032

   Absent

57

47

10

 

   Present

60

39

21

 

CD133

   

0.003

   Low

78

64

14

 

   High

39

22

17

 

TGF-β2

   

0.029

   Absent

72

58

14

 

   Present

45

28

17

 
  1. Pearson χ2 test.
  2. Statistical significance (P < 0.05) is shown in bold.
  3. #Partial data are not available, and the statistic was based on available.
  4. aRALYL absent: Samples without RALYL detection by qRT-PCR; RALYL present: Samples detected with RALYL expression by qRT-PCR.
Back to article page